Liquid Biopsy Market was valued at USD 2.4 Bn in 2020 and is expected to reach USD 7.1 Bn by 2027, with a growing CAGR of 19.9%. The increasing prevalence of various tumors and clinical trials are expected to propel the liquid biopsy market. The high adoption rate of liquid biopsy is one of the prominent driving factors of it
Sign in to leave a comment.